United States - English - NLM (National Library of Medicine)

octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic f

United States - English - NLM (National Library of Medicine)

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui

United States - English - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 5 g in 20 ml - emergency treatment of hypovolemic shock plasbumin-25 is hyperoncotic and on intravenous infusion will expand the plasma volume by an additional amount, three to four times the volume actually administered, by withdrawing fluid from the interstitial spaces, provided the patient is normally hydrated interstitially or there is interstitial edema.(1) if the patient is dehydrated, additional crystalloids must be given,(4) or alternatively, albumin (human) 5%, usp (plasbumin® -5) should be used. the patient’s hemodynamic response should be monitored and the usual precautions against circulatory overload observed. the total dose should not exceed the level of albumin found in the normal individual, i.e., about 2 g per kg body weight in the absence of active bleeding. although plasbumin-5 is to be preferred for the usual volume deficits, plasbumin-25 with appropriate crystalloids may offer therapeutic advantages in oncotic deficits or in long-standing shock where treatment has been delayed.(2) removal of ascitic flu

United States - English - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 2.5 g in 50 ml - emergency treatment of hypovolemic shock plasbumin-5 is iso-oncotic with normal plasma and on intravenous infusion will expand the circulating blood volume by an amount approximately equal to the volume infused. in conditions associated mainly with a volume deficit, albumin is best administered as a 5% solution (plasbumin-5); but where there is an oncotic deficit, albumin (human) 25%, usp (plasbumin® -25) may be preferred. this is also an important consideration where the treatment of the shock state has been delayed. if plasbumin-25 is used, appropriate additional crystalloid should be administered.(1) crystalloid solutions in volumes several times greater than that of plasbumin-5 may be effective in treating shock in younger individuals who have no preexisting illness at the time of the incident. older patients, especially those with preexisting debilitating conditions, or those in whom the shock is caused by a medical disorder, or where the state of shock has existed for some time before active therapy cou

United States - English - NLM (National Library of Medicine)

octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic

United States - English - NLM (National Library of Medicine)

octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular

United States - English - NLM (National Library of Medicine)

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular fu

United States - English - NLM (National Library of Medicine)

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui

Singapore - English - HSA (Health Sciences Authority)

euro asia medico pte. ltd. - albumin (human) - injection - 20% w/v - albumin (human) 20% w/v

Singapore - English - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - albumin (human serum) (venous) - infusion, solution - 0.2 g/ml - albumin (human serum) (venous) 0.2 g/ml